Zai Lab Reports 40% Confirmed Response Rate in Previously Treated epNEC
Updated Phase 1b/2 data showed zocilurtatug pelitecan produced a confirmed 40.0% objective response rate.
Updated Phase 1b/2 data showed zocilurtatug pelitecan produced a confirmed 40.0% objective response rate.